Cannell & Spears’s Clorox CLX Stock Holding History

Cannell & Spears’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,632	Closed	-$201K	–	416
2025 Q3	$201K	Buy	+1,632	New	+$203K	﹤0.01%	382

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cannell & Spears's CLX Position: Q4 2025 in Review

Cannell & Spears sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,632 shares — an estimated $201K sold.

Cannell & Spears first reported a position in CLX in Q3 2025 and held it in 1 quarter. The position peaked at $201K in Q3 2025. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

Cannell & Spears reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
Cannell & Spears sold 1,632 Clorox shares in Q4 2025, an estimated $201K.
Cannell & Spears first reported a position in Clorox in Q3 2025 and held it in 1 quarter.
Cannell & Spears's Clorox position peaked at $201K in Q3 2025.
1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Cannell & Spears's 13F filing for Q4 2025, filed 17 Feb 2026.